Susan G. Komen For the Cure foundation announced Friday it would reverse its controversial decision to cut financial support for Planned Parenthood breast exams.
The policy flop comes after days of widespread backlash over the loss of more than $600,000 in grant money for clinic breast health programs.
Today, Susan G. Komen founder and CEO Nancy G. Brinker said in a statement that the research advocacy group's decision to end funding for providers under investigation was not politically motivated, explains the L.A. Times.
Brinker said the policy was not meant to single out Planned Parenthood, an organization currently under congressional investigation by Rep. Cliff Stearns (R-Fla.) to determine if federal funding was used for abortion services.
"We will amend the criteria to make clear that disqualifying investigations must be criminal and conclusive in nature and not political. That is what is right and fair," the statement said.
Is a stem cell research controversy next?